Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinoma

INTRODUCTON: We wanted to identify the prognostic factors for overall survival (OS) in Chinese patients with metastatic renal cell carcinoma (mRCC) treated with first-line targeted therapy (sorafenib or sunitinib). METHODS: We retrospectively reviewed clinical data from 119 mRCC patients administere...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Can Urol Assoc J
Prif Awduron: Zhao, Juping, Huang, Xin, Sun, Fukang, Ma, Renyi, Wang, Haofei, Shao, Kun, Zhu, Yu, Zhou, Wenlong, Xu, Zhaoping, Shen, Zhoujun
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Canadian Medical Association 2014
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4250247/
https://ncbi.nlm.nih.gov/pubmed/25485010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2096
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg